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Abstract
Background: Valproate, thalidomide and alcohol (ethanol) exposure during the first trimester of
pregnancy is known to cause several developmental disorders. All these teratogens are known to
pass the placental barrier and interfere directly with the normal development of the fetus.
However, these teratogens also alter the formation and function of the placenta itself which may
in turn affect the proper nourishment and development of the fetus. Optimum development of the
placenta requires adequate invasion of trophoblast into the maternal uterine tissues. Changes in
the migratory behavior of trophoblast by maternal exposure to these teratogens during
placentogenesis may therefore alter the structure and function of the placenta.
Methods: In the present study, the effects of sodium valproate, thalidomide and alcohol on the
migration of human first trimester trophoblast cell line (HTR-8/SVneo) were examined in vitro.
Cells were cultured in the wells of 48-well culture plates as mono or multilayers. Circular patches
of cells were removed from the center of the wells by suction, and the migration of cells into the
wound was studied using microscopy. Effects of low and high concentrations of valproate,
thalidomide and alcohol were examined on the healing of wounds and on the migration rate of cells
by determining the wound areas at 0, 3, 6, 12, 24 and 48 h. Effects of drugs and alcohol on the
proliferation and the expression levels of integrin subunits beta1 and alpha5 in cells were examined.
Results: The migration rates of trophoblast differed between wounds created in mono and
multilayers of cells. Exposure to teratogens altered the migration of trophoblast into mono and
multilayer wounds. The effects of valproate, thalidomide and alcohol on the proliferation of cells
during the rapid migratory phase were mild. Drug exposure caused significant changes in the
expression levels of beta1 and alpha5 integrin subunits.
Conclusion: Results suggest that exposure to valproate, thalidomide or alcohol during the first
trimester of pregnancy may change the ultrastructure of the placenta by altering the migration of
trophoblast cells and this effect may be mediated by drug- or alcohol-induced changes in the
expression levels of beta1 and alpha5 integrin subunits.
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Background
Epidemiological findings and studies with animal models
reveal that impaired growth in utero and size at birth are
critical determinants of the onset of various disease proc-
esses later in life [1]. Optimum intrauterine growth
depends on several factors including proper nourishment
of the developing fetus by maternal blood through the
placenta [2]. Accordingly, proper development of the pla-
centa plays a significant role in determining the health
and well being of the offspring. Trophoblasts, the outer
layer of cells in the blastocyst, not only facilitate its attach-
ment with the uterine epithelium but play a significant
role in the formation of the placenta by invading the uter-
ine tissue and differentiating into several cell types with
endocrine, vascular, immunological or transport func-
tions [3]. Therefore, interference with trophoblast inva-
sion may result in abnormal development of the placenta
resulting in suboptimal nourishment to the fetus.
Drugs cross the placental barrier by ultrafiltration, diffu-
sion, active transport or by special processes, such as pino-
cytosis, or through breaks in placental wall and access the
developing fetus [4]. Valproate sodium (VPA), used in the
treatment of epilepsy and bipolar disease, is lipophilic, is
actively transported into the trophoblast, and crosses the
placenta through passive diffusion and by interacting with
placental carnitine transporter [5-8]. Valproate therapy
during pregnancy causes a wide range of congenital and
behavioral malformations in children [9]. Animal studies
demonstrate histopathological changes in the extraem-
bryonic and embryonic tissues, such as necrosis of
cytotrophoblasts and suppressed proliferation of fetal
capillaries, following exposure to valproic acid [10,11].
The immunomodulatory and anticancer drug thalido-
mide (THA) also passes through the placental barrier and
causes several defects in children including neurobehavio-
ral problems, ear and limb malformations [12]. Although
use of this drug during pregnancy is prohibited in the
United States, it remains a potential teratogen in many
parts of the world [13-15]. Exposure to thalidomide
increases mitotic activity of cytotrophoblast, forming
irregular masses of cells with or without syncytiotrophob-
last surrounding it, forming structures identical to embry-
oid bodies [16,17]. Alcohol (ethanol; ALC) diffuses across
the placenta and affects the developmental program of the
fetus at many levels resulting in fetal alcohol syndrome
[18]. Exposure to alcohol during pregnancy increases the
number and size of trophoblasts and dilates cisterns of
rough endoplasmic reticulum. Alcohol during pregnancy
causes hyperplasia of capillary basal lamina, hypertrophy
of trophoblastic basal lamina, irregular vascularization
and hyperemia at the basal zone and labyrinth of placenta
[19,20]. All three teratogens change the proliferation and
migration of various cell types in vitro and in vivo [21-23]
and cause placental pathologies [10,11,16,24-26]. Thus it
is possible that these teratogens may alter the number and
the invasion of trophoblasts, changing placental
ultrastructure.
To date, no study has been conducted to examine the
effects of these teratogens on the migration and prolifera-
tion of human placental trophoblast. Therefore in this
study, the effects of valproate, thalidomide and alcohol
on the migration and proliferation of first trimester tro-
phoblast cell line were examined in vitro. Because dose of
toxicant is a critical determinant of developmental toxicity
and is likely to be a key factor responsible for interspecies
variability in response to many test agents [27], both low
and high concentrations of drugs and alcohol were tested
on the trophoblast cells. Since trophoblasts invade mater-
nal tissues in multiple layers [28,29], migration assays
were conducted both in mono and multilayers to examine
the effects of drugs and alcohol on the migration of tro-
phoblast in multiple layers. Moreover because changes in
α5β1 integrin receptor-mediated adhesion are known to
alter migration of trophoblast [30], the effects of val-
proate, thalidomide or alcohol exposure on the expres-
sion levels of β1 and α5 integrin subunits were examined
in the trophoblast cell line in culture by Western blotting.
Methods
HTR cell culture and migration assays
HTR-8/SVneo cells were obtained from Dr. Charles H.
Graham (Queen's University, Ontario, Canada). Cells
were maintained in 75 cm2  flasks (Fisher Scientific,
Suwanee, GA) containing 40 ml RPMI 1640 medium sup-
plemented with 10% fetal calf serum (both from Invitro-
gen, Carlsbad, CA), 200 μg/ml Streptomycin sulfate and
200 U/ml penicillin G sodium (Invitrogen) as described
earlier [31,32]. Migration assays were conducted in wells
of 48-well plates (Corning; Fisher Scientific) containing
500 μl culture medium. For mono and multilayer studies,
approximately 600,000 and 1,800,000 cells respectively
were plated in each well the day before the experiment.
The next morning, cells in the center of the well were
removed by suction using a sterile pipette tip. Unattached
cells were removed immediately by removing existing
medium in the well and washing the attached layer of
cells twice with 500 μl of preincubated medium. Within 5
minutes, bright field images of the wells consisting of
areas with removed cells were captured at 4× for zero hour
data collection by a Nikon Eclipse Microscope supported
by Metamorph software (Molecular Devices Corp., Sun-
nyvale, CA). Plates were incubated for 48 h in the absence
(controls) or presence of valproate, thalidomide or ethyl
alcohol and images of wells were captured at 3, 6, 12, 24
and 48 h of culture.
Stock solutions of Valproate (50 mg/ml) and thalidomide
(56 mg/ml) were prepared in sterile water and DMSOReproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
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respectively as suggested by the supplier (Sigma-Aldrich,
St. Louis, MO). Further dilutions of valproate and thalid-
omide were conducted in the culture medium. Thalido-
mide at 100 μM contained 0.05% DMSO. Preliminary
experiments were conducted to ensure that DMSO at this
concentration did not alter the migration of cells in mono
or multilayers within 48 h of culture (data not shown).
Ethyl alcohol (200 proof; Sigma-Aldrich) solutions were
prepared in the culture medium. High and low concentra-
tions of these teratogens for the study were determined
from published articles to ensure that the concentrations
used would not increase cellular apoptosis and were suit-
able for migration assays [23,33-35]. At the completion of
image acquisition, wound areas (μm2) not encroached
upon by the migrating cells were derived using the draw-
ing tool and algorithms of Metamorph software. Data
were exported to Excel software and the change in area
with time was represented as a percentage of zero hour
data of each well. Migration rates (μm2/h) in control and
treated trophoblast cells between two image acquisition
times were determined by dividing the differences in per-
centage wound areas by the time (h) difference.
RT-PCR detection of integrin subunit
Expression of various integrin subunits in the HTR-8/
SVneo cells were examined by RT-PCR method. In brief,
total RNA from monolayer of cells cultured for 12 h was
isolated using RNeasy Mini kit (QIAGEN Inc., Valencia,
CA). The concentration of RNA in solution was deter-
mined using a NanoDrop spectrophotometer (NanoDrop
Technology, Inc., Rockland, DE). Total RNA (1 μg) was
treated with DNase I to remove traces of DNA and sub-
jected to reverse transcription using Superscipt III reverse
transcriptase. Complementary DNA (cDNA) equivalent to
50 ng of total RNA was used for PCR reactions. Reagents
used for cDNA synthesis and PCR reactions were from
Invitrogen Inc. Primer sequences for the amplification of
cDNA representing transcripts for α2, α3, α4, α5, α6, β1 and
β3 integrin subunits were obtained from published articles
[36-39]. Primer3 Input software (http://frodo.wi.mit.edu/
cgi-bin/primer3/primer3.cgi) was used to determine sense
(5'-GTGAGCTGCTTCAACATCCA-3') and antisense (5'-
TCTCTCAAAGCCCTCGA CAT-3') primers for the amplifi-
cation of αIIb  integrin subunit mRNA from published
human αIIb subunit cDNA sequence (Accession number
M34480). Amplicon representing αIIb  subunit mRNA
from the HTR-8/SVneo cells were purified from the gel
using QIAGEN gel extraction kit (QIAGEN, Inc.) and
sequenced using a commercially available service (Retro-
gen, Inc., San Diego, CA). The sequence (genBank Acces-
sion number DQ841705) was subjected to BLAST search
to confirm the identity.
Cell proliferation assays
Because valproate, thalidomide and alcohol alter prolifer-
ation of cells in culture, effects of these drugs were exam-
ined on the number of HTR cells to determine influence
of cell-number on the -migration data. Cells were plated
in 96-well plates to examine the effects of valproate, tha-
lidomide and alcohol on cell proliferation using a Cell-
Quant kit (Invitrogen) and a VICTOR 1420 Multilabeled
fluorescence detector (PerkinElmer, Fremont, CA). At 3 h,
the first batches of assays were conducted to determine
fluorescence intensities in wells plated with an increasing
number of cells. This data was plotted to determine the
linear range of the assay, and the slope was used to deter-
mine the relationship between the number of cells and
fluorescence intensities. At 3 h, cells in some plates were
treated with pre-equilibrated medium containing differ-
ent concentrations of valproate, thalidomide, or alcohol.
The medium of control wells was replaced with only pre-
equilibrated medium. After 12 h, fluorescence intensities
from untreated and treated cells were measured to deter-
mine the number of cells per well.
Western blotting
Expression levels of integrin subunits were examined in
cells at 3 h and 12 h after drug exposure. Cells were cul-
tured in 6-well plates containing 5 ml of culture medium
at 75% confluence. The next day, the medium was
removed and replaced with 5 ml of pre-incubated
medium supplemented with the drug or alcohol. Control
wells were supplemented with medium only. High and
low concentrations of each drug were used to determine
the effects of concentration on integrin subunit expres-
sion. At the time of lysate preparation, incubation
medium from control and treated wells was discarded.
Attached cells were washed with cold phosphate buffered
saline (PBS) and lysed with lysis buffer containing a pro-
teinase inhibitor cocktail (Pierce, Rockland, IL). Lysate
were centrifuged at 4°C and the supernatants were stored
at -20°C. Protein concentrations in the supernatant were
determined using a BCA protein assay kit (Pierce) on a
NanoDrop spectrophotometer. Lysate supernatants were
mixed with denaturing lane marker (Pierce) and heated in
a boiling water bath for 5 min. Equivalent amounts of
denatured proteins (10 μg) were subjected to 10% SDS-
polyacrylamide gel electrophoresis and separated proteins
were blotted onto nitrocellulose membranes using equip-
ment and reagents from BioRad Labs. Membranes were
blocked with 10% non-fat dry milk solution in PBS con-
taining 0.1% Tween-20 (TTBS) and subjected to incuba-
tion with primary antibody (BD Biosciences Pharmingen,
Franklin Lakes, NJ) in 5% blocking reagent overnight at
4°C. Membranes were washed three times with TTBS and
exposed for 1 h to peroxidase conjugated secondary anti-
body (Jackson Immunoresearch, West Grove, PA). Mem-
branes were washed in TTBS and treated with ECLReproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
Page 4 of 15
(page number not for citation purposes)
solutions (Amersham Biosciences Corp., NJ) for the
chemiluminescence detection of bands and for acquiring
images in tagged format using a Kodak 440 imaging sys-
tem. To avoid data fluctuations due to experiment-to-
experiment variations in the intensity of bands from con-
trol and treated samples, membranes containing
untreated and specific drug- or alcohol-treated samples
were processed simultaneously for the detection of an
integrin subunit. Membranes were first probed with the
human reactive monoclonal antibody against β1 integrin
subunit (clone 18) at 1:2,500 dilutions, stripped and rep-
robed with monoclonal antibody against α5 (clone 1)
integrin subunit at 1:5000 dilutions. Both antibodies were
obtained from BD Biosciences. Images were analyzed
using ImageJ software http://rsb.info.nih.gov/ij/ to deter-
mine the intensities of bands in arbitrary units. Intensity
data representing the expression level of each integrin
subunit from valproate-, thalidomide- or alcohol-treated
cells were subjected to statistical analysis with the
untreated samples of the same blot separately.
Statistical analysis
Post-hoc test was performed using SPSS software (SPSS
Inc., Chicago, IL) to compare individual mean ± standard
deviations of mean values obtained by repeated measure
ANOVA to determine the significance of difference. Dif-
ferences between means at p < 0.05 were considered sig-
nificant. Wound areas from 6 individual wells were
obtained from 3 independent experiments each consist-
ing of two controls and treated wells (N = 6). Cell num-
bers were determined from two independent experiments
each consisting of 8 wells (N = 16). Band intensities for
particular integrin subunit were determined from two
independent experiments, each consisting of two repli-
cates (N = 4).
Results
Migration of HTR-8/SVneo cells in mono vs. multiple layers 
(Figure 1)
Suction wound areas (μm2) created in mono (1237279 ±
376135) and multilayers (934459 + 386014) of cells were
not significantly different (p > 0.05). Wounds created in
multilayers of cells healed faster than those in monolayer
(Figure 1A). Wound areas were significantly lower in mul-
tilayer compared with monolayer cells as early as 3 h of
creation and remained lower throughout the course,
reaching about 1% at 24 h (Figure 1B). The earlier healing
of wounds in multilayer cells was due to a significantly
higher rate of migration (μm2/h) of cells, commencing as
early as the initial 3 h of incubation (Figure 1C). The
migration rate in the multilayer wounds remained higher
until 12 h of incubation and then waned, healing the
wounds slowly sometime during 24 to 48 h of incubation.
Because most wounds in multilayer cells healed between
24 to 48 h of incubation and images were captured at 24
h and then at 48 h, it was not possible to calculate the
exact time of complete healing and therefore to derive the
rate of migration using the value of time (h). Due to this
reason, the migration rates of cells in multiple layers dur-
ing 24 to 48 h were not taken into consideration for the
data analysis. Wounds created in the monolayer healed
slowly but with a consistent rate except during 3 to 6 h of
incubation when the migration rate of cells was lowest.
Wounds in the monolayer were filled by 48 h. Percentage
wound areas (%) at 3, 6 and 12 hours of incubation
between the mono and multilayers of cells were signifi-
cantly different (p < 0.05).
Effects of valproate on HTR migration (Figure 2)
Valproate inhibited healing in both mono (Figure 2A)
and multilayers (Figure 2C) of cells, albeit more effec-
tively in the multilayer wounds. In monolayer wounds,
higher concentration (400 μM) of valproate inhibited
migration more than at lower concentration (100 μM),
whereas in multilayer wounds this effect was reversed.
Further analysis of migration data of multilayer wounds
revealed that this was due to a significant drop in the
migration rate of cells (Figure 2D) treated with 100 μM
VPA as early as 3 h of treatment. Later during 12 to 24 h,
the migration rate of cells in multilayer wounds treated
with 100 μM VPA increased but was not robust enough to
overcome the delay. In monolayer wounds, both low and
high concentrations of valproate inhibited the migration
rate during 6 to 12 h of incubation (Figure 2B), but later
(24 to 48 h) the migration rate of treated cells increased,
filling the wounds almost at the same incubation time as
controls.
Effects of thalidomide on HTR migration (Figure 3)
Thalidomide, like valproate, inhibited healing both in
mono (Figure 3A) and multilayer wounds (Figure 3C),
though more at lower (25 μM) than at higher (100 μM)
concentration. This inhibitory effect of thalidomide on
healing was more prominent with the monolayer
wounds. Analysis of the rate of migration data revealed
that both in mono (Figure 3B) and multilayer wounds
(Figure 3D), thalidomide affected the migration rate sig-
nificantly between 6 to 12 h of incubation at both low and
high concentrations. However, the inhibitory effects of
low concentrations of thalidomide commenced as early as
3 h of incubation in monolayer wounds. Nevertheless, in
both control and treated cells, wounds healed almost at
the same time, i.e., about 48 h in monolayer wounds and
24 h in the multilayer wounds.
Effects of alcohol on HTR migration (Figure 4)
Effects of alcohol on healing was opposite between mono
and multilayer wounds. Alcohol accelerated healing in
monolayer wounds (Figure 4A), whereas it delayed heal-
ing in multilayer wounds (Figure 4C). The acceleratingReproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
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Healing and migration rate of cells were faster in multilayer wounds Figure 1
Healing and migration rate of cells were faster in multilayer wounds. A. Bright field images showing suction-wounds 
created in the monolayer (upper panel) and multilayer (lower panel) of cells at 0, 12, 24 and 36 h of incubation. Contrasts of 
images are increased to visualize the wound areas not invaded by the migrating cells. Bar Size 400 μm. B. Mean ± standard 
deviations of mean of wounds areas (μm2) during healing. Wound areas reduced to ~20% within 24 and 12 h of incubation in 
the monolayer (❍) and multilayer (●) respectively. Complete healing of wound occurred earlier and by 24 h in multilayer cells. 
C. Mean ± standard deviations of mean of % migration rate of cells (μm2/h). Migration rate (%) in the multilayer wounds (■) 
remained higher until 12 h of incubation compared to those created in the mono layer () of cells. * p < 0.05
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effects of alcohol on the monolayer wound healing were
higher at high concentration (100 mM), whereas the
inhibitory effects of alcohol on the multilayer wounds
were only observed with low concentration of alcohol (25
mM). Analysis of the migration rate of cells revealed that
the accelerating effects of alcohol on the migration rate of
cells in monolayer wounds were most prominent between
3 to 6 h of incubation (Figure 4B). The inhibitory effects
of low concentration (25 mM) alcohol on multilayer
wounds were persistent until 12 h of incubation (Figure
4D). In both control and alcohol-treated cells, wounds
healed almost at the same time, i.e., about 48 h in monol-
ayer and 24 h in the multilayer cells.
Migration rate data (Figures 2B, 2D, 3B, 3D, 4B and 4D)
presented in tabulated format (Table 1) revealed that the
exposure of cells with a drug or alcohol influenced the rate
of migration mostly during 6 to 12 h of incubation. Tha-
lidomide consistently inhibited the migration rate of cells
in both mono and multilayer wounds during this time
period. Exposure to low concentrations of valproate or
alcohol invariably altered the migration rate of cells in
multilayer wounds during the entire incubation period,
specifically inhibiting the migration rate during 0 to 12 h
of incubation.
Valproate reduced healing and migration rate of cells in mono (A & B) and multilayers (C & D) Figure 2
Valproate reduced healing and migration rate of cells in mono (A & B) and multilayers (C & D). A. Mean ± stand-
ard deviations of wound areas (%) in monolayer cells. Wounds exposed to high concentration of valproate were significantly 
larger (*) than controls as early as 12 h of incubation and this difference was maximum by 24 h. Wounds exposed to low con-
centration of valproate were also larger than controls starting as early as 12 h of incubation but this difference was significant 
(**) only at 24 h of incubation. Differences in wound areas between the low and high valproate concentrations were not signif-
icant. B. Mean ± standard deviations of % migration rates (μm2/h) of cells in monolayer cells. Valproate at high and low concen-
trations changed the migration rate of cells throughout the course of assay. However, it was significantly reduced during 6 to 
12 h and increased during 24 to 48 h. C. Mean ± standard deviations of wound areas (%) in multilayer cells. Wounds exposed 
to low concentration of valproate were significantly larger than controls at 3 h of treatments and this difference was at its max-
imum by 12 h of incubation. D. Mean ± standard deviations of % migration rates (μm2/h) of cells in multilayers. Both high and 
low concentrations of valproate inhibited migration rate of cells until 12 h. Symbols Monolayer wounds (❍), Multilayer 
wounds (●), Control (-) or () High drug concentration (--) or (■), Low drug concentration (...) or ( ). *, ** p < 0.05.
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VPA, THA and ALC effects on the expression of integrin 
subunits in HTR cells (Figures 5 and 6)
Transcripts of αIIb, α2, α3, α4, α5, αv, α6, β1 and β3
integrin subunits were detected by RT-PCR experiments
(Figure 5A). Bands representing integrin subunit β1 (~130
kDa) and α5 (~150 kDa) were detected in control and
treated cells at 3 and 12 h of incubation by Western blot-
ting (Figure 5B).
Expression levels of β1 (Figure 6; left panels) and α5 (Fig-
ure 6; right panels) integrin subunits increased with time
in untreated cells (p < 0.05). Treatment of cells with val-
proate, thalidomide or alcohol changed the expression
levels of β1 and  α5 subunits, but the patterns of these
changes were similar for thalidomide and alcohol treat-
ments only. Exposure to high concentration of valproate
for 3 h decreased expression levels of β1 subunit (Figure
6A) but increased expression of α5 subunit (Figure 6B).
Treatments with high or low concentrations of valproate
for 12 h did not alter expression levels of β1 integrin sub-
units, but decreased the expression levels of α5 subunit,
albeit significantly (p < 0.05) with only the high concen-
tration of drug.
Thalidomide and alcohol treatments for 3 and 12 h
changed the expression pattern of β1 and α5 subunits in a
Thalidomide reduced healing and migration rate of cells in mono (A & B) and multilayers (C & D) Figure 3
Thalidomide reduced healing and migration rate of cells in mono (A & B) and multilayers (C & D). A. Mean ± 
standard deviations of wound areas (%) in monolayer cells. Wounds exposed to low concentration of thalidomide were signif-
icantly larger than controls by 3 h of incubation and this difference increased to maximum by 24 h of incubation. B. Mean ± 
standard deviations of % migration rates (μm2/h) of cells in monolayer. Migration rates of cells were significantly reduced by 
treatments with low concentration of thalidomide as early as 3 h of incubation. Later, during 6 to 12 h, the migration rate was 
reduced by low or high concentrations of thalidomide. At later phase of treatments (24 to 48 h), both high and low concentra-
tions thalidomide increased the migration rate. C. Mean ± standard deviations of wound areas (%) in multilayer cells. Wounds 
exposed to low or higher concentration of thalidomide were significantly larger than controls (*) by 12 h of treatments. D. 
Mean ± standard deviations of % migration rates (μm2/h) of cells in multilayer. Migration rates during 3 to 6 h were significantly 
lower in wounds treated with high concentrations of thalidomide. Later, during 6 to 12 h, both low and high concentrations of 
thalidomide reduced the migration rate of cells. Symbols Monolayer wounds (❍), Multilayer wounds (●), Control (-) or () 
High drug concentration (--) or (■), Low drug concentration (......) or ( ). * p < 0.05.
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similar manner, though not always significantly. For
instance, treatments with low or high concentrations of
thalidomide for 3 h increased expression levels of both β1
(Figure 6C) and α5 (Figure 6D) integrin subunits. Further-
more, this pattern was maintained even when treatments
were prolonged for 12 h, although the difference between
the low concentration of thalidomide and untreated cells
was not statistically significant (p > 0.05). Similar to tha-
lidomide, exposure of cells to alcohol for 3 and 12 h
increased expression levels of β1 (Figure 6E) and α5 subu-
nits (Figure 6F), except that the increase in α5 expression
with high concentration of alcohol treatment was mild
and not statistically significant from the respective control
(untreated cells). Therefore, the patterns of β1 and  α5
expression levels in cells were similar following thalido-
mide and alcohol treatments for 3 and 12 h, but were dif-
ferent than those with valproate treatments. This is
obvious from the Western blot data presented in the tab-
ulated format (Table 2).
Effects of VPA, THA and ALC on the proliferation of cells 
(Figure 7)
Differences in the number of untreated cells between 3 to
12 h of culture were not statistically significant (p > 0.05).
However, the number of cells treated for 12 h with low
concentrations of thalidomide (25 μM) or low (25 mM)
Alcohol influenced healing and migration rate of cells differently in mono (A and B) and multilayers (C and D) Figure 4
Alcohol influenced healing and migration rate of cells differently in mono (A and B) and multilayers (C and D). 
A. Mean ± standard deviations of wound areas (%) in monolayer cells. Alcohol at high concentration significantly reduced 
wound areas in monolayer of cells by 6 and 12 h of incubation. Differences in areas between low and high alcohol concentra-
tion treated wounds were not significantly different. B. Mean ± standard deviations of % migration rates (μm2/h) of cells in 
monolayer. Alcohol at high and low concentrations increased migration rate of cells during 3 to 12 h of incubation. Later dur-
ing 6 to 12 h of treatments, migration rates were increased significantly by only high concentrations of alcohol. C. Mean ± 
standard deviations of wound areas (%) in multilayer cells. Wounds treated with low concentration of alcohol were larger than 
the controls and those treated with high concentration of alcohol by 3 h of incubation and this difference was at its maximum 
by 12 h of incubation. D. Mean ± standard deviations of % migration rates (μm2/h) of cells in multilayers. In multilayer wounds, 
alcohol at low concentration inhibited migration rate of cells until 12 h. Later (12 to 24 h) the migration rate of cells treated 
with low concentrations of alcohol was higher than control and those treated with high concentration of alcohol. Symbols 
Monolayer wounds (❍), Multilayer wounds (●), Control (-) or (), High drug concentration (--) or (■), Low drug concentra-
tion (...) or ( ). * p < 0.05.
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or high (100 mM) concentrations of alcohol increased sig-
nificantly (p < 0.05) from the untreated cells cultured
simultaneously for 12 h.
Discussion
This study reports a novel way of studying cell migration
in vitro using suction-wounds that can be created using a
sterile tip and a vacuum unit. This method is superior to
conventionally used scratch assays because wounds with
comparable perimeter can be created in wells that allow
examining cell migration and healing in relatively similar
wounds. In addition, the entire wound area can be visual-
ized under low magnification (4×) for study. This obviates
measurement errors during imaging at different times of
culture that is common with conventional scratch assays
and occur because of differences in the width of the
wound along the length of the scratch.
The results suggest that valproate, thalidomide and alco-
hol may influence migration of human first trimester tro-
phoblast. Therefore, exposure to these teratogens during
the first trimester of pregnancy may interfere with the nor-
mal development of placenta. This may cause suboptimal
nourishment of developing embryos resulting in develop-
mental defects. Results demonstrate that the changes in
the migration rate of human first trimester trophoblast
after drug and alcohol treatments may result from the
alteration in the expression levels of β1 and α5 integrin
subunits.
Data presented here reveal for the first time that the migra-
tion rates of cells in monolayer, and as reported in several
studies using scratch assays, differ from those of cells in
multilayers, a situation that is relatively more realistic to
what is seen in vivo [28,29]. Although experiments con-
ducted do not explain the mechanisms for the differences
in the migration rate of cells between mono or multilayer
wounds, it is likely that the accelerated migration of cells
in multilayers wounds is due to better enrichment of
medium with the cell migration enhancing factors
secreted by relatively larger number of cells per well. These
molecules may include extracellular matrix proteins regu-
lating trophoblast migration, cytokines (TGF-β), growth
factors (IGF-II), decorin, plaminogen activators, endothe-
lin-1 and hormones regulating trophoblast migration [40-
48]. Therefore, migration of invading trophoblast in vivo,
where they invade in multiple layers [28,29], may be
favored by the sufficiency of these molecules.
All three teratogens tested in this study are reported to
alter the migration of different cell types, albeit differ-
ently. In vitro tests show that valproate may increase or
decrease the migration of different glioma cell lines
[49,50] and neural crest cells individually or in sheets
[49]. Thalidomide changes the migration of cells differ-
ently at different concentrations [51] and cell type. It
increases migration of multiple myeloma cells and inhib-
its migration of human keratinocytes [52,53]. Valproate
and thalidomide exposure during prenatal development
causes abnormal positioning of serotonergic neurons in
rats [22], and migration of cortical neurons in rat fetal
brains are delayed following prenatal exposure to alcohol
[21]. There are numerous reports on alcohol's ability to
alter the migration of various cell types, including mouse
trophoblast, in culture differently [23,54-58]. Therefore, it
is obvious that these teratogens target cell migration
machinery differently in different cell types depending
upon the concentration and cellular milieu. Data pre-
sented here also demonstrate that drugs and alcohol
change the migration rate of trophoblast differently
Table 1: Effects of drug and alcohol on the migration rate of HTR-8/SVneo cells
Drug/Alcohol Cell Layer/s Concentration 0–3 h 3–6 h 6–12 h 12–24 h 24–48 h
VPA Mono High -- -- ↓ -- ↑
Low -- -- ↓ -- ↑
Multi High -- -- -- -- nd
Low ↓↓ ↓ ↑ nd
THA Mono High -- -- ↓ -- ↑
Low ↓ -- ↓ -- ↑
Multi High -- ↓↓ ↑ nd
Low ↑ -- ↓↑nd
ALC Mono High -- ↑↑ -- --
Low -- ↑ -- -- --
Multi High -- -- ↓ -- nd
Low ↓↓ ↓ ↑ nd
Arrows Significantly different from the respective control at p < 0.05. (Direction of arrows shows changes in the migration rate); nd Migration rate 
not determined.
(---) Not Significantly different from the respective control.Reproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
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Expression of integrin subunit mRNA species and drug effects on the expression levels of β1 and α5 integrin subunits Figure 5
Expression of integrin subunit mRNA species and drug effects on the expression levels of β1 and α5 integrin 
subunits. A. RT-PCR amplification of integrin subunit mRNA species. Transcripts representing integrin subunits were 
amplified by RT-PCR. Amplicons subjected to Agarose gel electrophoresis, stained with ethidium bromide and photographed. 
Amplicons representing αIIb (570 bp), α2 (541 bp), α3A(656 bp), α4 (484 bp), α5 (564 bp), αv (619 bp), α6 (A 420 bp and B 550 
bp), β1 (300 bp), β3 (200 bp) integrin subunits and β actin (478 bp) transcripts from HTR-8/SVneo cells are shown in lanes 1, 2, 
3, 4, 5, 6, 7, 8, 9 and 10 respectively. L: 100 bp molecular weight markers. B. Western blots of integrin subunits β1 and α5 
in control and treated HTR cells. Composite of representative blots showing expression levels of β1 and α5 integrin subu-
nits in HTR cells at 3 and 12 h of incubation in absence (control) or presence of low or high concentrations of drugs or alcohol. 
Integrin subunit bands from two separate experiments (of total four), each consisting of lysate from 3 and 12 h incubation are 
shown in adjacent lanes. Treatment conditions and integrin subunits are mentioned on the right of each blot. Incubation peri-
ods of cells in absence or presence of drugs are shown below the composite.
A
B
 3   3  12 12 
Time (h) Reproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
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depending upon concentration and cell density (Table 1).
Therefore, it is possible that exposure to these teratogens
during placentogenesis may influence invasion of first tri-
mester trophoblast differently depending upon the dos-
age and the cellular surroundings. The disparity in the
effects of low concentrations of alcohol on the migration
of cells between mono and multilayers supports this pos-
sibility. Differences in the drug- or alcohol-induced
changes in the migration rates between the mono and
multilayer wounds may derive from the capacity of each
drug to influence secretion of ECM and factors influenc-
ing migration machinery, and possibly may be due to
their ability to change the cell-plate and cell-cell interac-
tions.
Expression of integrin subunit α6, α5 and β1 mRNA, and
the roles of α6β1, α6β4, α1β1, α2β1, α5β1, αvβ1 and αvβ3
integrin receptors regulating the migration of trophoblast
were reported earlier [31,59-61]. Data presented here pro-
vide evidence for the expression of α3A,  α4, and αIIb
integrin subunit mRNA and splicing of α6 integrin tran-
scripts in a first trimester human trophoblast cell line.
Detection of αIIb mRNA in first trimester trophoblast cell
line and a recent report describing the role of αIIbβ3
integrin receptor in trophoblast migration in mice [28]
implies possible involvement of this receptor in the
migration of human trophoblast. Additionally, the exist-
ence of α6A and α6B mRNA splice variants in the human
trophoblast cell line hint for additional regulatory con-
Drug-induced changes in the expression levels of β1 and α5 integrin subunits Figure 6
Drug-induced changes in the expression levels of β1 and α5 integrin subunits. Mean ± standard deviations of mean 
values of integrin subunit band intensities derived from 4 separate Western blotting experiments. Cells at 75% confluence 
were treated with low or high concentrations of valproate (A & B), thalidomide (C & D) or alcohol (E & F). Drug treatments in 
culture changed intensities of β1 (left panels) and α5 (right panels) integrin subunit bands. Drug concentrations and the time of 
exposures are shown below each bar. Symbols Controls (), High (■) and Low drug ( ) concentration. * p < 0.05.
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trols of trophoblast invasion mediated by α6β1 or α6β4
receptors [61-63].
Western blotting data show that valproate, as well as tha-
lidomide and alcohol, changes the expression levels of β1
and α5 integrin subunits. Therefore treatments with these
drugs or alcohol may alter the migration of trophoblasts
by changing the availability of subunits for the formation
of active α5β1 integrin receptors on the cell surface. West-
ern blot data presented in the tabulated format (Table 2)
reveal that the pattern of changes in the expression levels
of  β1  and  α5 subunits by thalidomide or alcohol are
almost similar, whereas valproate altered the expression
levels of β1 and α5 integrin subunits differently. Nonethe-
less, it is likely that exposure to these drugs and alcohol
during first trimester of pregnancy may alter the invasion
of trophoblasts by disturbing the subunit stoichiometry
during the formation of functional α5β1 receptors.
Enhanced adhesion of trophoblasts by α5β1 receptor is
shown to inhibit the invasion of human trophoblasts
[30], but this model may not completely explain changes
in the migration rate of trophoblasts following alcohol
treatments. This is because alcohol increased α5 and β1
integrin subunit levels at both low and high concentra-
tions but accelerated migration of trophoblasts in monol-
ayer and inhibited in multilayer wounds. These results
indicate that expression levels of β1 and α5 integrin subu-
nits may not be the sole determining factor for the migra-
tion rate of cells. Obviously, changes in the expression
pattern of other integrin subunits α1, α2, αv, α6, αIIb, β3
and  β4 that are known to be expressed in trophoblast
[28,30,62,63], and down-stream molecules regulating
integrin-mediated migration may also account for these
differences. Besides, because cell migration is a dynamic
process, changes in the expression of these molecules may
not be steady during the course of migration. Therefore,
studying steady state levels of integrin subunit expression
pattern may not completely explain the migratory behav-
ior of cells. Studies of molecules regulating cell migration
Effects of Valproate, Thalidomide and Alcohol on the prolif- eration of trophoblast Figure 7
Effects of Valproate, Thalidomide and Alcohol on the 
proliferation of trophoblast. Mean ± standard deviations 
of the number of HTR cells in culture in the absence and 
presence of a drug or alcohol. Number of cells between 3 
and 12 h of incubations were not significantly different (p > 
0.05) in untreated cells (controls). Treatments with low and 
high concentrations of valproate for 12 h did not alter cell 
numbers from untreated cells (12 h control) significantly (p > 
0.05). Treatments with thalidomide at low concentration and 
alcohol at both low and high concentrations for 12 h 
increased number of cells significantly from the controls. 
Treatment conditions and time of incubations are shown 
below each bar. * Significantly different from controls at p < 
0.05. Symbols Controls (), Valproate (■), Thalidomide 
() ,  A l c o h o l  () .
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Table 2: Drug or alcohol induced changes in the expression levels of β1 and α5 integrin subunits in HTR-8/SVneo cells
Drug/Alcohol Treatment Period Concentration Integrin Subunit β1 Integrin Subunit α5
VPA 3 h High ↓* ↑*
Low -- ↑*
12 h High -- ↓*
Low ↑↓
THA 3 h High ↑* ↑*
Low ↑* ↑*
12 h High ↑* ↑*
Low ↑ --
ALC 3 h High ↑* ↑
Low ↑* ↑*
12 h High ↑* ↑
Low ↑* ↑*
Arrows Expression levels of integrin subunit relative to respective control (untreated cells).
* Significantly different from the respective control at p < 0.05.
(---) No change from the respective controls.Reproductive Biology and Endocrinology 2006, 4:44 http://www.rbej.com/content/4/1/44
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in real-time in untreated and treated cells may be required
to further clarify the mechanisms.
Valproate, thalidomide and alcohol influence prolifera-
tion of various cells [53,64-68]. Therefore, changes in the
number of trophoblasts caused by these teratogens during
the migration assay may influence the healing rates of the
wounds. To examine the extent of this possibility, efficacy
of low and high concentrations of teratogens on the
number of trophoblasts was tested in a time frame rele-
vant to the early phase of healing (3 and 12 h), when the
migration rates were rapid. Data obtained indicated that
changes in cell numbers due to treatments were mild and
significant only at low concentrations of thalidomide or
both at low and high concentrations of alcohol. There-
fore, treatment of cells with these drugs is not likely to
influence the migration rate of trophoblasts robustly.
Besides, changes in the number of cells did not correlate
with changes in the migration rate of cells. For instance,
12 h of treatment with 25 μM thalidomide increased the
cell numbers significantly, but the migration of cells at
this concentration was inhibited. Similarly, alcohol at low
concentration increased the number of cells more than
those treated with high concentration for 12 h, while the
migration rate of cells in monolayer wounds was acceler-
ated more by high concentration of alcohol during 3 to 12
h. These observations suggest that changes in the migra-
tion rate of cells were not influenced significantly by dif-
ferences in proliferation rates induced by treatments, at
least during the initial 12 h of incubation.
It is possible that in vivo effects of drugs on the migration
and proliferation of trophoblasts may not be the same as
those observed in this cell line tested in vitro. For instance,
valproate inhibits human sperm motility differently in
vivo as compared to in vitro conditions [69]. Maternal gen-
otype regulating metabolism of drugs and alcohol may
also influence the outcome [47,70]. In addition, the direct
action of teratogens tested on cells in culture may not be
same as those occurring due to the drug or alcohol and
their metabolites in vivo. Therefore, data obtained in vitro
will require verification in control and drug-exposed
human placentas of different genotypes.
One of the likely consequences of poor trophoblast
migration and invasion is the development of preeclamp-
sia. Increased risk of preeclampsia due to valproate ther-
apy is reported [71], but no association between
thalidomide exposure or maternal alcohol drinking with
preeclampsia is known so far. Therefore, it is likely that
disturbances in the development of placenta due to
changes in the invasiveness of trophoblast may not be the
sole determining factors for the risk of preeclampsia. Of
the three teratogens tested in this study, only valproate
may influence these additional factor/s.
Conclusion
All teratogens tested in this study are known to change the
development and function of the placenta in human and
animal models (see Introduction). Results from this study
suggest that these placental pathologies may partly be due
to alterations in the migration rate of trophoblasts by
drugs or alcohol exposure, possibly mediated by changes
in the expression levels of α5β1 integrin receptors in the
trophoblast. Because wounds finally heal even under
treated conditions, it is anticipated that trophoblasts
attain their destination despite prenatal exposure to val-
proate, thalidomide or alcohol. Therefore, it is the tempo-
ral changes in the interaction of trophoblasts with the
external milieu resulting from its altered pace of invasion
that possibly adds to the placental anomaly.
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